TickerFacts.

TriSalus Life Sciences, Inc. (TLSI): Operating Cash Flow

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$18.01M
Year ended 2025-12-31
-$22.80M
Trailing 12 months to 2026-06-30
2021-12-31: -$1.74M2022-12-31: -$32.31M2023-12-31: -$50.58M2024-12-31: -$40.84M2025-12-31: -$18.01M-$18.01M
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$18.01Mn/m2026-03-05, From 2025-01-01
2024-12-31-$40.84Mn/m2026-03-05, From 2024-01-01
2023-12-31-$50.58Mn/c2025-05-30, From 2023-01-01
2022-12-31-$32.31Mn/m2024-04-11, From 2022-01-01
2021-12-31-$1.74Mn/a2023-03-22, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$18.01Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$3.88M+57.9%
Shoulder Innovations, Inc. (SI)2025-12-31-$28.61Mn/m
SS Innovations International, Inc. (SSII)2025-12-31-$18.54Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31$462.4Kn/m
Carlsmed, Inc. (CARL)2025-12-31-$28.98Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$5.83M+25.5%
Apyx Medical Corp (APYX)2025-12-31-$8.00Mn/m
Utah Medical Products Inc (UTMD)2025-12-31$14.69M-0.9%

Compare TLSI, SNWV, SI, SSII side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗